Rapid Onset of Effect of Galcanezumab for the Prevention of Episodic Migraine: Analysis of the EVOLVE Studies
Headache The Journal of Head and Face Pain2019Vol. 60(2), pp. 348–359
Citations Over TimeTop 10% of 2019 papers
Holland C. Detke, Brian A. Millen, Qi Zhang, Karen Samaan, Jessica Ailani, David W. Dodick, Sheena K. Aurora
Abstract
Rapid onset of preventive effect on the first day after injection of galcanezumab was confirmed in both studies of episodic migraine.
Related Papers
- → Episodic and Chronic Migraine Headache: Breaking Down Barriers to Optimal Treatment and Prevention(2015)316 cited
- → CGRP-targeted medication in chronic migraine - systematic review(2024)45 cited
- → Is calcitonin gene-related peptide a reliable biochemical marker of migraine?(2022)23 cited
- → A Quantification of the Placebo Response in Migraine Prophylaxis(2002)94 cited
- → Plasma Calcitonin Gene-Related Peptide in Diagnosing and Predicting Paediatric Migraine(2009)53 cited